RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @Dr_Khan: Intensive care management of #coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/Tax5QXxrmZ /via…
Intensive care management of #coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/Tax5QXxrmZ /via @LancetRespirMed #COVID19 #COVID https://t.co/B0rnAnUP0H
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
@JEverettLearned There's very little data available on covid outcomes (by which I mean 8), at most you get case studies for one or a few hospitals but without the underlying data they are based on its basically just hogwash. That being said: https://t.co/
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @stephen_t_webb: Superb review of ICU management of #COVID19 by Jason Phua et al in @LancetRespirMed https://t.co/w5W826VWjW https://t.c…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @stephen_t_webb: Superb review of ICU management of #COVID19 by Jason Phua et al in @LancetRespirMed https://t.co/w5W826VWjW https://t.c…
RT @stephen_t_webb: Superb review of ICU management of #COVID19 by Jason Phua et al in @LancetRespirMed https://t.co/w5W826VWjW https://t.c…
Información para especialistas 👇 Medicina
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @stephen_t_webb: Superb review of ICU management of #COVID19 by Jason Phua et al in @LancetRespirMed https://t.co/w5W826VWjW https://t.c…
Superb review of ICU management of #COVID19 by Jason Phua et al in @LancetRespirMed https://t.co/w5W826VWjW https://t.co/GyNPhtmCmn
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
Must read!
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
RT @accpchest: Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 vi…
Intensive care management of #coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/27iGVZeav7 via @TheLancet #CHESTCritCare https://t.co/E5Yycx8Tgy
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/FGYozUA5M7
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @ProDdx: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/jqJfojcBQD
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @manozom: Revisión de The Lancet sobre el Covid-19 y su tratamiento https://t.co/CJ2z1xTioo
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @manozom: Revisión de The Lancet sobre el Covid-19 y su tratamiento https://t.co/CJ2z1xTioo
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @ChristophHutchi: While things are clearly evolving in what we know and how we manage this disease this is a great overview of #ICU mana…
Intensive care management of coronavirus disease (COVID-19): challenges and recommendations https://t.co/LK4bgXJ7Pz #covid19 #intensivecare #lancet #recommendations
RT @GeertJeelof: Mag hopen dat @rivm deze keer wel de medische vakliteratuur bijhoudt.
RT @hrkz1985: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations - The Lancet Respiratory Med…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
🔥online 6April by @TheLancet #COVID19 Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/lnYuJKaYZ5 by https://t.co/5NcTxBfXmk President, Society of Intensive Care Medicine, Singapore https://t.
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @DRTomlinsonEP: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations - The Lancet Respirator…
RT @DRTomlinsonEP: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations - The Lancet Respirator…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/VUX7PH5NGA
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations - The Lancet Respiratory Medicine #COVID19 https://t.co/2twkKhZzrc
RT @StephenLap: Superb overview of all aspects of #COVID19 ICU management from Singapore (by @ccmtoronto alumnus): https://t.co/tFodG4FgNC
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
@HanishaSethi @SputnikInt @NeilClark66 @afshinrattansi @Underground_RT @RTUKnews @CDubenskij_RT @PeterGOliver_RT
@nadiratudor @CarlosOrtizMoho @Polly_Boiko @afshinrattansi @NeilClark66 @NastiaChurkina @arbolioto @LauraSmith_RT @RTUKproducer @RussiaNow @KatePartridge33 @NikkiAaronRT With Boris Johnson in hospital this may provide a useful read for background informati
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
Does Odisha have 12% of positive COVID-19 patients, ICU beds? In Italy, the country outside China with the most patients with COVID-19 until March 29, 2020, up to 12% of all positive cases required ICU admission. https://t.co/T4e17UnbBJ https://t.co/AMQt
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…